Cloud-based Elite platform to roll out to Roche's laboratory network across 50+ countries and a target 1,000 installations over five years. BASEL, Switzerland, March 18, 2025 /PRNewswire/ ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) ...

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) ...

Gazyva/Gazyvaro is the only anti-CD20 monoclonal antibody in a randomised phase III study to demonstrate a complete renal response benefit1 The filing application is based on data from the phase ...

Roche’s RHHBY member company, Genentech, announced the FDA approval of TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke (AIS) in adults ...

At this time, I would like to welcome everyone to the On Holdings AG Q4 and Fiscal Year 2024 Results ... Through a playful conversation about our logo, the two literally put the name of our ...

Get Our Latest Research Report on ONON ON Stock Up 3.8 % ONON opened at $48.45 on Monday. On Holding AG has a 52 week low of $27.37 and a 52 week high of $64.05. The business has a fifty day ...

View Our Latest Report on Roche Roche Trading Up 0.7 % RHHBY opened at $41.74 on Friday. Roche Holding AG has a fifty-two week low of $29.20 and a fifty-two week high of $42.43. The company’s 50 ...

The chart above depicts the trend in analyst earnings per share (EPS) forecasts for Roche Holding AG for the upcoming quarter. Analysts have not changed this quarter's expectations for EPS over the ...